Materialise Buys FEops

Materialise has acquired FEops, a Belgian company that develops artificial intelligence-driven simulation technology to improve procedure efficiency and clinical outcomes for structural heart interventions, Materialise reports. The acquisition will allow Materialise to expand its cardiovascular solutions with predictive simulation capabilities, advancing the personalized treatment of patients with heart diseases. The amount of the transaction was not disclosed.

FEops combines predictive simulation technology and artificial intelligence, allowing clinicians to more accurately predict how transcatheter structural heart devices will interact with a patient’s anatomy, the company explains. Materialise’s Mimics Planner for Structural Heart Interventions, a solution for segmentation and anatomical analysis, planning, and design, enables the creation of accurate virtual 3D models based on medical image data.

With the integration of FEops, the Mimics Planner will offer a solution for anatomy-based 3D planning and AI-based simulation, allowing clinicians to simulate the interaction between a medical device, such as a heart valve, and a patient’s unique anatomy. 

"At Materialise, we are pioneering the advent of mass personalization in healthcare, using advanced visualization and 3D printing technologies to deliver precise, patient-specific solutions,” says Brigitte de Vet, CEO of Materialise. “By integrating FEops’ advanced predictive simulation technology with our Mimics Planner, we are expanding our cardiovascular solutions to provide clinicians with comprehensive insights into patient anatomy. This integration will not only enhance the accuracy and efficiency of structural heart interventions but also improve clinical outcomes and patient safety.”

Materialise is advancing mass personalization in healthcare by facilitating the creation of image-based virtual 3D models for pre-procedural planning, enhancing the precision and success of complex procedures. These models enable the creation of personalized medical devices, guides, and implants tailored to the precise anatomical specifications of individual patients.

Sources: Press materials received from the company and additional information gleaned from the company’s website.